• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS PRECICONTROL HIV; MULTI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS PRECICONTROL HIV; MULTI-ANALYTE CONTROLS, ALL KINDS (ASSAYED) Back to Search Results
Catalog Number 05162645190
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/01/2018
Event Type  Injury  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).In general, post exposure management includes multiple consecutive steps such as: initial cleansing of the exposed area, defining the exposure and determination of (b)(6) status of the source of the exposure.Intact skin is an effective barrier against (b)(6) infection, and contamination of intact skin with blood or other potentially contaminated fluids is not considered an exposure and does not require post-exposure prophylaxis.
 
Event Description
The user accidentally spilled (b)(6) solution on her finger.The user was not wearing gloves; she washed her hands with soap and water.Product labeling states "however, as no inactivation or testing method can rule out the potential risk of infection with absolute certainty, the material should be handled with the same level of care as a patient specimen." in this case, the user did not take the proper precautions.The user went to the doctor in the infectious diseases department where they considered the precicontrol hiv material to be potentially infectious.Diagnostic blood testing was performed but the results are not yet available.The user was prescribed and is currently taking 2 antiretroviral drugs: isentress (raltegravir) and truvada (emtricitabine / tenofovir).
 
Manufacturer Narrative
(b)(6) testing was performed on (b)(6) 2018 and the results were (b)(6).Following the (b)(6) results, the user stopped taking the antiretroviral drugs she had been prescribed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS PRECICONTROL HIV
Type of Device
MULTI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7464403
MDR Text Key106636068
Report Number1823260-2018-01293
Device Sequence Number1
Product Code JJY
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
BP160050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number05162645190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/02/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-